These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 20524315
1. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Manitpisitkul W, Wilson N, Cooper M, Gurk-Turner C, Hurley H, Rasetto F, KuKuruga D, Barth RN, Philosophe B. Clin Transpl; 2009; ():461-3. PubMed ID: 20524315 [No Abstract] [Full Text] [Related]
8. Bortezomib for the treatment of de novo HLA antibody-related antibody mediated rejection. Al Meshari K. Clin Transpl; 2009; ():385-6. PubMed ID: 20524302 [No Abstract] [Full Text] [Related]
14. Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases. Mai HL, Cesbron A, Brouard S, Blanchol G, Cantarovich D, Dantal J, Hourmant M, Lino M, Meurette A, Gosselin M, Abbadie O, Soulillou JP, Giral M. Clin Transpl; 2009; ():361-8. PubMed ID: 20524299 [No Abstract] [Full Text] [Related]
15. Abrogation of anti-HLA antibodies via proteasome inhibition. Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD. Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494 [Abstract] [Full Text] [Related]
17. Proteasome inhibitor treatment of antibody-mediated allograft rejection. Woodle ES, Alloway RR, Girnita A. Curr Opin Organ Transplant; 2011 Aug 27; 16(4):434-8. PubMed ID: 21753709 [Abstract] [Full Text] [Related]
18. Bortezomib for antibody mediated rejection treatment: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City. Leyva S, Marino-Vázquez LA, Reyes-Loaeza JA, Vega O, Uribe-Uribe N, Alberú J, Morales-Buenrostro LE. Clin Transpl; 2009 Aug 27; ():369-76. PubMed ID: 20524300 [Abstract] [Full Text] [Related]
19. Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line? Lee I, Constantinescu S, Gillespie A, Swami A, Birkenbach M, Leech S, Silva P, Karachristos A, Daller JA, Sifontis NM. Clin Transpl; 2009 Aug 27; ():425-9. PubMed ID: 20524309 [No Abstract] [Full Text] [Related]
20. Protective immunity remains intact after antibody removal by means of proteasome inhibition. Everly MJ, Terasaki PI, Hopfield J, Trivedi HL, Kaneku H. Transplantation; 2010 Dec 27; 90(12):1493-8. PubMed ID: 21042236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]